Axcelis Technologies, Inc. (NASDAQ:ACLS) Shares Acquired by Quest Partners LLC

Quest Partners LLC increased its stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) by 51.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,975 shares of the semiconductor company’s stock after acquiring an additional 1,346 shares during the period. Quest Partners LLC’s holdings in Axcelis Technologies were worth $417,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the stock. Reinhart Partners LLC. increased its holdings in shares of Axcelis Technologies by 64.1% during the 3rd quarter. Reinhart Partners LLC. now owns 687,608 shares of the semiconductor company’s stock valued at $72,096,000 after purchasing an additional 268,560 shares in the last quarter. Boston Trust Walden Corp purchased a new position in Axcelis Technologies in the third quarter valued at $53,099,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its position in shares of Axcelis Technologies by 7.7% in the second quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 455,846 shares of the semiconductor company’s stock worth $64,816,000 after acquiring an additional 32,695 shares during the period. American Century Companies Inc. boosted its stake in shares of Axcelis Technologies by 11.2% during the 2nd quarter. American Century Companies Inc. now owns 385,181 shares of the semiconductor company’s stock worth $54,769,000 after acquiring an additional 38,827 shares in the last quarter. Finally, Paradigm Capital Management Inc. NY grew its position in shares of Axcelis Technologies by 5.9% during the 2nd quarter. Paradigm Capital Management Inc. NY now owns 349,200 shares of the semiconductor company’s stock valued at $49,653,000 after acquiring an additional 19,400 shares during the period. 89.98% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

ACLS has been the topic of a number of recent analyst reports. Needham & Company LLC reiterated a “hold” rating on shares of Axcelis Technologies in a research report on Friday, November 8th. B. Riley decreased their target price on Axcelis Technologies from $190.00 to $165.00 and set a “buy” rating on the stock in a research report on Friday, August 2nd. Finally, Benchmark lowered shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a report on Friday, November 8th. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, Axcelis Technologies currently has an average rating of “Moderate Buy” and a consensus price target of $167.33.

Axcelis Technologies Stock Up 2.4 %

Shares of ACLS opened at $75.07 on Monday. The stock has a 50 day moving average price of $91.99 and a 200 day moving average price of $111.20. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.29 and a current ratio of 4.45. The stock has a market capitalization of $2.44 billion, a price-to-earnings ratio of 11.11, a PEG ratio of 2.28 and a beta of 1.60. Axcelis Technologies, Inc. has a one year low of $69.35 and a one year high of $158.61.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.